RICHMOND, Va. (AP) — GlaxoSmithKline will pay Virginia more than $2 million as part of a settlement between the drug maker and 45 states.
Attorney General Mark R. Herring says the $105 million settlement resolves allegations that GlaxoSmithKline improperly marketed the asthma drug Advair and two antidepressant drugs.
Recommended Stories
Print subscriber? Click here to login/register your account
Digital subscriber? Click here to login/register your account.